Hyder A Jinnah1, Jan K Teller, Wendy R Galpern. 1. aDepartment of Neurology, Human Genetics & Pediatrics, Emory University, Atlanta, Georgia bDystonia Medical Research Foundation, Chicago, Illinois cNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: The dystonias are a family of related disorders with many different clinical manifestations and causes. This review summarizes recent developments regarding these disorders, focusing mainly on advances with direct clinical relevance from the past 2 years. RECENT FINDINGS: The dystonias are generally defined by their clinical characteristics, rather than by their underlying genetic or neuropathological defects. The many varied clinical manifestations and causes contribute to the fact that they are one of the most poorly recognized of all movement disorders. A series of recent publications has addressed these issues, offering a revised definition and more logical means for classifying the many subtypes. Our understanding of the genetic and neurobiological mechanisms responsible for different types of dystonias also has grown rapidly, creating new opportunities and challenges for diagnosis, and identifying increasing numbers of rare subtypes for which specific treatments are available. SUMMARY: Recent advances in describing the clinical phenotypes and determining associated causes have pointed to the need for new strategies for diagnosis, classification, and treatment of the dystonias.
PURPOSE OF REVIEW: The dystonias are a family of related disorders with many different clinical manifestations and causes. This review summarizes recent developments regarding these disorders, focusing mainly on advances with direct clinical relevance from the past 2 years. RECENT FINDINGS: The dystonias are generally defined by their clinical characteristics, rather than by their underlying genetic or neuropathological defects. The many varied clinical manifestations and causes contribute to the fact that they are one of the most poorly recognized of all movement disorders. A series of recent publications has addressed these issues, offering a revised definition and more logical means for classifying the many subtypes. Our understanding of the genetic and neurobiological mechanisms responsible for different types of dystonias also has grown rapidly, creating new opportunities and challenges for diagnosis, and identifying increasing numbers of rare subtypes for which specific treatments are available. SUMMARY: Recent advances in describing the clinical phenotypes and determining associated causes have pointed to the need for new strategies for diagnosis, classification, and treatment of the dystonias.
Authors: Claudia Dufke; Marc Sturm; Christopher Schroeder; Susanne Moll; Thomas Ott; Olaf Riess; Peter Bauer; Kathrin Grundmann Journal: Mov Disord Date: 2014-01-09 Impact factor: 10.338
Authors: Valerija Dobričić; Nikola Kresojević; Ana Westenberger; Marina Svetel; Aleksandra Tomić; Vesna Ralić; Igor Petrović; Milica Ječmenica Lukić; Katja Lohmann; Ivana Novaković; Christine Klein; Vladimir S Kostić Journal: Mov Disord Date: 2014-04-13 Impact factor: 10.338
Authors: Evan Tiderington; Emily M Goodman; Ami R Rosen; Edie R Hapner; Michael M Johns; Marian L Evatt; Alan Freeman; Stewart Factor; H A Jinnah Journal: J Neurol Sci Date: 2013-08-30 Impact factor: 3.181
Authors: Justus L Groen; Katja Ritz; Michael W Tanck; Bart P van de Warrenburg; Jacobus J van Hilten; Majid Aramideh; Frank Baas; Marina A J Tijssen Journal: Mov Disord Date: 2013-03-04 Impact factor: 10.338
Authors: Gavin Charlesworth; Vincent Plagnol; Kira M Holmström; Jose Bras; Una-Marie Sheerin; Elisavet Preza; Ignacio Rubio-Agusti; Mina Ryten; Susanne A Schneider; Maria Stamelou; Daniah Trabzuni; Andrey Y Abramov; Kailash P Bhatia; Nicholas W Wood Journal: Am J Hum Genet Date: 2012-11-29 Impact factor: 11.025